Drug Discovery Innovators & Investors Digital Forum offers certificate of attendance
Join us on 30 September for the Drug Discovery Innovators & Investors (DDII) Digital Forum, where experts from across the drug discovery ecosystem explore the technologies, strategies, therapies and investment trends shaping early-stage drug discovery.
The Forum is free to attend. Register for the full event, or simply join one of the four sessions that interest you most. All attendees will receive a certificate of attendance.
Session 1: Beyond Borders — Building a Collaborative and Resilient Drug Discovery Ecosystem
Key takeaways:
- How companies are managing scale-up challenges, regulatory and geographic barriers.
- How to allocate resources effectively across clinical stages.
- Real-world examples of therapeutic companies operating in a turbulent market.
Moderated by Reece Armstrong (Editor, DDW), with panelists from Basel Area Business & Innovation, Polaryx Therapeutics, Renexxion and Curia.
Session 2: Working Smarter — Strategies for Improving Lab Effectiveness
Key takeaways:
- How new technology is expediting the drug discovery and development process.
- Why lean methodologies matter and how to apply them.
- Ways to optimise workflows, increase efficiency and reduce waste.
- What to prioritise when upgrading lab technology.
Moderated by Diana Turner (DDW Content Team), with speakers from Intrepid Labs, Oxford North and CSEM.
Session 3: Therapies and Modalities Changing Global Drug Discovery
Key takeaways:
- How commercial planning and research are managed across emerging modalities.
- How researchers, start-ups and academics can maximise new opportunities and overcome key challenges.
- How advanced scientific approaches are helping address hard-to-treat diseases.
- How these shifts are accelerating drug development pipelines.
Moderated by Megan Thomas (DDW Content Team), with speakers from University of Cambridge, Cancer Research Horizons, Elasmogen/ONE Life Sciences and Amphista Therapeutics.
Session 4: Where Next? Emerging Markets, Capital Flow and the New Frontiers of Drug Discovery
Key takeaways:
- Which technologies are driving impact in today’s drug discovery processes, and how to access that advantage.
- How capital is flowing into emerging areas, and what’s really driving it: data, technology or hype.
- What 2026 has looked like so far in terms of financing, plus lessons from China.
- How venture funding can be accessed, how biotech hubs grow, and how new drug development can be encouraged in the current climate.
Moderated by Patrik Frei (Venture Valuation Inc and Biotechgate), with speakers from Breakout Ventures, Medicines Discovery Catapult and Link Biologics.
Register here for Europe Forum: https://event.gotowebinar.com/event/bab960cb-c367-42c1-b4f5-9b8c0c9e6acd
Register here for Americas Forum: https://event.gotowebinar.com/event/36348c15-804c-4f9a-8b43-e67bd9c449b6
The Digital Forum is supported by Lead Sponsor Curia.
